Shantha Biotechnics Limited engages in the development, manufacture, and marketing of recombinant human healthcare products in India. The company develops generic biologicals, novel therapeutic antibodies, proteins, and vaccines. It conducts research in the fields of oncology, infectious diseases, and platform technologies.The company provides contract research services in the areas of gene cloning, monoclonal antibody development, expression and purification of recombinant proteins by fermentation, fermentation/purification process optimization, development of polyclonal antibodies, and development of WCB and MCB, as well as contract manufacturing services. It serves the Asia-Pacific, Africa, CIS, and Latin America markets. The company was founded in 1993 and is based in Hyderabad, India.